BHST
BIOHARVEST SCI (BHST)
NASDAQ
$3.17+$0.12 (+3.77%)
Price as of Jun 23, 2026 4:10 PM EDT
  • $69.1M
    Market Cap
  • -55.34%
    1-Year Change
  • Packaged Foods
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 11
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$3.05
$3.38
$3.05
1-Year Range
$3.02
$12.65
$3.05
Latest Close$3.05
Change
-$0.21 (-6.89%)
Volume37,523
Market Cap$69.1M
Shares Outstanding22.7M
P/E (TTM)-5.08
Diluted EPS (TTM)-$0.60
Enterprise Value$46.3M

Information as of 06/22/2026

Company Profile

BIOHARVEST SCIENCES INC
BIOHARVEST SCIENCES INC
https://www.bioharvest.com
$69.1M
Market Cap
-$11.1M
Net Income
Sector: Consumer Defensive
Industry: Packaged Foods
1140-625 Howe Street, Vancouver, BC, Canada, V6C 2T6
604 622 1186

BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.

Key Executives

  • Zaki Rakib
  • Ilan Sobel
  • Yoheved Hagay
  • Ilana Belzer
  • Jared Turner

Current Ownership Distribution

  • Other15.6M (90.12%)
  • Institutions1.7M (9.82%)
  • Mutual Funds11,576 (0.07%)
  • Insiders0 (0.00%)